Methylphenidate-Induced Stuttering in a Patient With Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder: A Case Report
Despite that the relationship between MPH and stuttering is not well-documented, it is important to recognize that side effects may arise when initiating treatment or increasing the dosage. Typically, quitting the medication is sufficient to alleviate these side effects. Further studies are needed to better understand the side effects and mechanisms of action associated with MPH.
Authors
- İbrahim Adak (ORCID: https://orcid.org/0000-0001-9057-9017)
- Ozalp Ekıncı (ORCID: https://orcid.org/0000-0001-9598-8944)
- İpek Süzer Gamlı (ORCID: https://orcid.org/0000-0002-6514-0157)
- İ.O. Yıldırım (ORCID: https://orcid.org/0000-0003-3179-9823)
Institutions
- Bakırköy Psychiatric Hospital (TR)
- NOF Corporation (Japan) (JP)
- Sağlık Bilimleri Üniversitesi (TR)
Publication Details
- Journal
- Clinical Neuropharmacology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1097/wnf.0000000000000640
- Primary Topic
- Autism Spectrum Disorder Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00